North Bristol NHS Trust has joined forces with academics from the University of Bristol, University of Cambridge and Queen's University Belfast to run a multi-centre clinical trial on a drug which could help in the fight against Alzheimer's disease (AD). Currently losartan is used for controlling high blood pressure, but researchers believe that it could help to improve blood flow to the brain and slow down the progression of Alzheimer's. Approximately 800,000 people in the UK are affected by the cognitive condition, which profoundly affects memory and brain function in older people. The Medical Research Council (MRC) has agreed to give the study £2 million in funding. This will enable the researchers to recruit around 230 participants at sites across the UK over the next two years. Dr Pat Kehoe, joint group head of the Dementia Research Group in the School of Clinical Sciences, said: "The trial, which involves leading dementia research centres in at least ten cities in the UK - including those across England, Scotland and Wales - should provide the first real evidence of losartan's potential benefit in AD." Find out more about dementia care and support services at Barchester homes.